PFK Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of PFK Antibodies for investigating phosphofructokinase (PFK) in cellular metabolism. PFK Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Phosphofructokinase serves as a key regulatory enzyme in the glycolytic pathway, playing a vital role in controlling glucose metabolism and energy production in cells. PFK activity maintains cellular homeostasis and responds to metabolic demands, making it an important focus for research in cancer, diabetes, and other metabolic disorders. Understanding phosphofructokinase function and regulation can provide insights into therapeutic strategies for various conditions. Researchers worldwide rely on PFK monoclonal antibodies to advance metabolic research and uncover new therapeutic targets. Ongoing studies of phosphofructokinase continue to reveal its significance in cellular processes and disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies enable researchers to make meaningful contributions to understanding metabolic pathways and developing potential treatments.